Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

This MongoDB Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Author: Avi Kapoor | May 20, 2025 08:32am

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Keybanc analyst Philip Gibbs downgraded the rating for ATI Inc. (NYSE:ATI) from Overweight to Sector Weight. ATI shares closed at $76.58 on Monday. See how other analysts view this stock.
  • HC Wainwright & Co. analyst Arthur He downgraded Prime Medicine, Inc. (NASDAQ:PRME) from Buy to Neutral. Prime Medicine shares closed at $1.3350 on Monday. See how other analysts view this stock.
  • Loop Capital analyst Yun Kim downgraded MongoDB, Inc. (NASDAQ:MDB) from Buy to Hold and lowered the price target from $350 to $190. MongoDB shares closed at $189.01 on Monday. See how other analysts view this stock.
  • JP Morgan analyst Eric Joseph downgraded the rating for Prime Medicine, Inc. (NASDAQ:PRME) from Overweight to Neutral. Prime Medicine shares closed at $1.3350 on Monday. See how other analysts view this stock.
  • Wells Fargo analyst Michael Sison downgraded the rating for Westlake Corporation (NYSE:WLK) from Overweight to Equal-Weight and cut the price target from $95 to $76. Westlake shares closed at $79.94 on Monday. See how other analysts view this stock.

Considering buying MDB stock? Here’s what analysts think:

Read This Next:

Photo via Shutterstock

Posted In: ATI MDB PRME WLK

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist